AU2002220255A1 - A monoclonal antibody-based diagnostic assay for gamma fibrinogen - Google Patents

A monoclonal antibody-based diagnostic assay for gamma fibrinogen

Info

Publication number
AU2002220255A1
AU2002220255A1 AU2002220255A AU2025502A AU2002220255A1 AU 2002220255 A1 AU2002220255 A1 AU 2002220255A1 AU 2002220255 A AU2002220255 A AU 2002220255A AU 2025502 A AU2025502 A AU 2025502A AU 2002220255 A1 AU2002220255 A1 AU 2002220255A1
Authority
AU
Australia
Prior art keywords
monoclonal antibody
diagnostic assay
based diagnostic
gamma fibrinogen
fibrinogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002220255A
Inventor
Hamid A. Al-Mondhiry
David H. Farrell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Penn State Research Foundation
Original Assignee
Penn State Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Penn State Research Foundation filed Critical Penn State Research Foundation
Publication of AU2002220255A1 publication Critical patent/AU2002220255A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/36—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745—Assays involving non-enzymic blood coagulation factors
    • G01N2333/75—Fibrin; Fibrinogen
AU2002220255A 2000-12-05 2001-12-05 A monoclonal antibody-based diagnostic assay for gamma fibrinogen Abandoned AU2002220255A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25129100P 2000-12-05 2000-12-05
US60/251,291 2000-12-05
PCT/US2001/047208 WO2002046769A2 (en) 2000-12-05 2001-12-05 A monoclonal antibody-based diagnostic assay for gamma fibrinogen

Publications (1)

Publication Number Publication Date
AU2002220255A1 true AU2002220255A1 (en) 2002-06-18

Family

ID=22951300

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002220255A Abandoned AU2002220255A1 (en) 2000-12-05 2001-12-05 A monoclonal antibody-based diagnostic assay for gamma fibrinogen

Country Status (3)

Country Link
US (1) US20030003515A1 (en)
AU (1) AU2002220255A1 (en)
WO (1) WO2002046769A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP971299A0 (en) * 1999-04-12 1999-05-06 South Eastern Sydney Area Health Service Procoagulant assay
US20130012603A1 (en) * 2010-03-15 2013-01-10 Farrell David H Methods for assessing the risk of cardiovascular disease
WO2016123163A2 (en) 2015-01-27 2016-08-04 Kardiatonos, Inc. Biomarkers of vascular disease

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU572125B2 (en) * 1983-03-17 1988-05-05 Mabco Limited Monoclonal antibodies with specificity for crosslinked fibrin and their diagnotic uses
US4722903A (en) * 1983-11-14 1988-02-02 New York Blood Center, Inc. Monoclonal antibodies specific to in vivo fragments derived from human fibrinogen, human fiberin I or human fibrin II
US4661471A (en) * 1984-04-10 1987-04-28 New England Deaconess Hospital Method of inhibiting and inducing human platelet aggregation
US4666884A (en) * 1984-04-10 1987-05-19 New England Deaconess Hospital Method of inhibiting binding of von Willebrand factor to human platelets and inducing interaction of platelets with vessel walls
US5114842A (en) * 1987-07-08 1992-05-19 The Scripps Research Institute Peptides and antibodies that inhibit platelet adhesion
US6124107A (en) * 1988-06-10 2000-09-26 Merck & Co., Inc. Assay for marker of human polymorphonuclear leukocyte elastase activity
US5196309A (en) * 1990-11-15 1993-03-23 The Scripps Research Institute Characterization of platelet aggregation disorders
KR100235575B1 (en) * 1991-06-27 1999-12-15 프랭크 쿵; 멜린다 그리피스, 데자딘스 캐서린 엠 Screening assay for the detection of dna-binding molecules
DE4133946A1 (en) * 1991-10-14 1993-04-15 Behringwerke Ag FUNCTIONAL TEST AND REAGENT FOR DETERMINING FIBRINOGEN
US5599790A (en) * 1992-06-11 1997-02-04 The Scripps Research Institute Fibrinogen γ chain polypeptide and compositions thereof
DE4242736A1 (en) * 1992-12-17 1994-06-23 Behringwerke Ag Synthetic peptides, antibodies against them and their use
EP0678524B1 (en) * 1993-11-02 2008-02-06 Mitsubishi Kagaku Iatron, Inc. Anti-human soluble fibrin antibodies, hybridoma producing them, and immunoassaying method
US5985833A (en) * 1996-09-17 1999-11-16 Wisconsin Alumni Research Foundation Thrombin inhibitor
FR2769093B1 (en) * 1997-09-30 1999-11-12 Pasteur Sanofi Diagnostics IN VITRO METHOD FOR ASSESSING THROMBOTIC RISKS BY MEASURING PLASMA FIBRINOGEN

Also Published As

Publication number Publication date
WO2002046769A3 (en) 2003-01-16
US20030003515A1 (en) 2003-01-02
WO2002046769A2 (en) 2002-06-13

Similar Documents

Publication Publication Date Title
HK1017080A1 (en) Front-end architecture for a measurement instrument.
AU2001239972A1 (en) Device having diarrhea diagnostic panel
IL156030A0 (en) Humanized antibodies
AU2001253239A1 (en) Contextual programming
IL155837A0 (en) A diagnostic system for the ear
AUPQ886100A0 (en) Diagnostic test
AU1174702A (en) Humanized anti-lt-beta-r antibodies
AU2002247765A1 (en) Device for referencing fluorescence signals
AU2003210511A1 (en) An immunochromatographic assay for emp
AU2001276498A1 (en) Apparatus for diagnostic assays
AU2001290952A1 (en) Scorecard wizard
IL143739A0 (en) Diagnostic assay
AU2001259841A1 (en) A diagnostic tool for a portable thread environment
AU2002222157A1 (en) Yeast-based assays involving gpcrs
AU2002357178A1 (en) Diagnostic assays for bcwa
AU2002220255A1 (en) A monoclonal antibody-based diagnostic assay for gamma fibrinogen
AU2002221132A1 (en) Novel antibody
AU5046700A (en) Diagnostic monoclonal antibody for LTiGTyersinia pestisLT/iGT
AU2002952702A0 (en) A diagnostic assay
AU2631799A (en) Odometer
EP1331481A4 (en) Diagnostic kit for schizophrenia
AU2002330185A1 (en) Diagnostic assay for antibiotic tolerance
AU2001295042A1 (en) Anti-stilbene antibodies
AU2001289613A1 (en) Reinforcement for construction surfaces
GB0028577D0 (en) Diagnostic Assays